The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
The functional loss of the retinoblastoma tumour suppressor is a common event in basal-like and luminal B breast carcinomas
Open accessAbstract
Introduction: Breast cancers can be classified using whole genome expression into distinct subtypes that show differences in prognosis. One of these groups, the basal-like subtype, is poorly differentiated, highly metastatic, genomically unstable, and contains specific genetic alterations such as the loss of tumour protein 53 (TP53). The loss of the retinoblastoma tumour suppressor encoded by the RB1 locus is a well-characterised occurrence in many tumour types; however, its role in breast cancer is less clear with many reports demonstrating a loss of heterozygosity that does not correlate with a loss of RB1 protein expression. Methods: We used gene expression analysis for tumour subtyping and polymorphic markers located at the RB1 locus to assess the frequency of loss of heterozygosity in 88 primary human breast carcinomas and their normal tissue genomic DNA samples. Results: RB1 loss of heterozygosity was observed at an overall frequency of 39%, with a high frequency in basal-like (72%) and luminal B (62%) tumours. These tumours also concurrently showed low expression of RB1 mRNA. p16 INK4a was highly expressed in basal-like tumours, presumably due to a previously reported feedback loop caused by RB1 loss. An RB1 loss of heterozygosity signature was developed and shown to be highly prognostic, and was potentially a predictive marker of response to neoadjuvant chemotherapy. Conclusions: These results suggest that the functional loss of RB1 is common in basal-like tumours, which may play a key role in dictating their aggressive biology and unique therapeutic responses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261
Self-citationSørlie, T., Perou, C. M., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., Hastie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191367098 · Cited by 10,938
Self-citationIn silico prediction of protein-protein interactions in human macrophages
Souiai, O., Guerfali, F., Ben Miled, S., Brun, C., & Benkahla, A. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-157 · Cited by 10,803
Significance analysis of microarrays applied to the ionizing radiation response
Tusher, V. G., Tibshirani, R., & Chu, G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091062498 · Cited by 10,568
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
van de Vijver, M. J., He, Y. D., van 't Veer, L. J., Dai, H., Hart, A. A. M., Voskuil, D. W., Schreiber, G. J., Peterse, J. L., Roberts, C., Marton, M. J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021967 · Cited by 6,488
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
Paik, S., Shak, S., Tang, G., Kim, C., Baker, J., Cronin, M., Baehner, F. L., Walker, M. G., Watson, D., Park, T., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041588 · Cited by 6,277
Repeated observation of breast tumor subtypes in independent gene expression data sets
Sørlie, T., Tibshirani, R., Parker, J., Hastie, T., Marron, J. S., Nobel, A., Deng, S., Johnsen, H., Pesich, R., Geisler, S., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0932692100 · Cited by 5,429
Self-citationSherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379
The retinoblastoma protein and cell cycle control
Weinberg, R. A. (1995) · Cell · doi:10.1016/0092-8674(95)90385-2 · Cited by 4,862
The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer Subtypes
Carey, L. A., Dees, E. C., Sawyer, L., Gatti, L., Moore, D. T., Collichio, F., Ollila, D. W., Sartor, C. I., Graham, M. L., & Perou, C. M. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1109 · Cited by 2,087
Self-citationBreast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy
Rouzier, R., Perou, C. M., Symmans, W. F., Ibrahim, N., Cristofanilli, M., Anderson, K., Hess, K. R., Stec, J., Ayers, M., Wagner, P., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2421 · Cited by 1,891
Self-citationThe molecular portraits of breast tumors are conserved across microarray platforms
Hu, Z., Fan, C., Oh, D. S., Marron, J., He, X., Qaqish, B. F., Livasy, C., Carey, L. A., Reynolds, E., Dressler, L., et al. (2006) · BMC Genomics · doi:10.1186/1471-2164-7-96 · Cited by 1,491
Self-citationGenomic and transcriptional aberrations linked to breast cancer pathophysiologies
Chin, K., DeVries, S., Fridlyand, J., Spellman, P. T., Roydasgupta, R., Kuo, W.-L., Lapuk, A., Neve, R. M., Qian, Z., Ryder, T., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.009 · Cited by 1,317
Herschkowitz, J. I., Simin, K., Weigman, V. J., Mikaelian, I., Usary, J., Hu, Z., Rasmussen, K. E., Jones, L. P., Assefnia, S., Chandrasekharan, S., et al. (2007) · Genome Biology · doi:10.1186/gb-2007-8-5-r76 · Cited by 1,285
Self-citationMiller, L. D., Smeds, J., George, J., Vega, V. B., Vergara, L., Ploner, A., Pawitan, Y., Hall, P., Klaar, S., Liu, E. T., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506230102 · Cited by 1,268
Cdk1 is sufficient to drive the mammalian cell cycle
Santamaría, D., Barrière, C., Cerqueira, A., Hunt, S., Tardy, C., Newton, K., Cáceres, J. F., Dubus, P., Malumbres, M., & Barbacid, M. (2007) · Nature · doi:10.1038/nature06046 · Cited by 1,114
Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma
Livasy, C. A., Karaca, G., Nanda, R., Tretiakova, M. S., Olopade, O. I., Moore, D. T., & Perou, C. M. (2006) · Modern Pathology · doi:10.1038/modpathol.3800528 · Cited by 1,063
Self-citationRetinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16
Lukas, J., Parry, D., Aagaard, L., Mann, D. J., Bartkova, J., Strauss, M., Peters, G., & Bartek, J. (1995) · Nature · doi:10.1038/375503a0 · Cited by 899
Hess, K. R., Anderson, K., Symmans, W. F., Valero, V., Ibrahim, N., Mejia, J. A., Booser, D., Theriault, R. L., Buzdar, A. U., Dempsey, P. J., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.05.6861 · Cited by 721
Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression
Chung, C. H., Parker, J. S., Karaca, G., Wu, J., Funkhouser, W. K., Moore, D., Butterfoss, D., Xiang, D., Zanation, A., Yin, X., et al. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00112-6 · Cited by 678
Self-citationExpression and amplification of cyclin genes in human breast cancer.
Buckley, M. F., Sweeney, K. J. E., Hamilton, J. A., Sini, R. L., Manning, D. L., Nicholson, R. I., DeFazio, A., Watts, C. K. W., Musgrove, E. A., & Sutherland, R. L. (1993) · PubMed · Cited by 667
Common markers of proliferation
Whitfield, M. L., George, L. K., Grant, G. D., & Perou, C. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1802 · Cited by 650 · cited 2×
“It should be noted, however, that several groups have independently identified different gene lists that contain a large number of so-called proliferation/RB-pathway genes [13,32-35] and it was expected that the RB-LOH signature would be a strong prognostic profile.”
BackgroundSelf-citationInactivation of the Retinoblastoma Susceptibility Gene in Human Breast Cancers
Lee, E. Y.-H. P., To, H., Shew, J.-Y., Bookstein, R., Scully, P., & Lee, W.-H. (1988) · Science · doi:10.1126/science.3388033 · Cited by 581
Structural Rearrangement of the Retinoblastoma Gene in Human Breast Carcinoma
T'Ang, A., Varley, J. M., Chakraborty, S., Murphree, A. L., & Fung, Y.-K. T. (1988) · Science · doi:10.1126/science.3175651 · Cited by 403
Li, Y., Nichols, M. A., Shay, J. W., & Xiong, Y. (1994) · PubMed · Cited by 359
Estrogen-Regulated Genes Predict Survival in Hormone Receptor–Positive Breast Cancers
Oh, D. S., Troester, M. A., Usary, J., Hu, Z., He, X., Fan, C., Wu, J., Carey, L. A., & Perou, C. M. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.2755 · Cited by 356
Self-citationDimaras, H., Khetan, V., Halliday, W., Orlic, M., Prigoda, N. L., Piovesan, B., Marrano, P., Corson, T. W., Eagle, R. C., Squire, J. A., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn024 · Cited by 351 · cited 1×
“As opposed to breast cancer, there is a great deal known about the mechanisms of RB1 loss in retinoblastoma [ 60-62 ].”
BackgroundWeigelt, B., Hu, Z., He, X., Livasy, C., Carey, L. A., Ewend, M. G., Glas, A. M., Perou, C. M., & van't Veer, L. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2553 · Cited by 332
Self-citationRichter, S., Vandezande, K., Chen, N., Zhang, K., Sutherland, J., Anderson, J., Han, L., Panton, R., Branco, P., & Gallie, B. (2003) · The American Journal of Human Genetics · doi:10.1086/345651 · Cited by 328
Kotake, Y., Cao, R., Viatour, P., Sage, J., Zhang, Y., & Xiong, Y. (2007) · Genes & Development · doi:10.1101/gad.1499407 · Cited by 311
Brenner, A. J., Stampfer, M. R., & Aldaz, C. M. (1998) · Oncogene · doi:10.1038/sj.onc.1201919 · Cited by 272 · cited 1×
“It has been shown that in order for human mammary epithelial cells to proliferate in vitro in culture for an extended period they must overcome an RB-mediated stress associated senescence barrier (stasis), which usually involves spontaneously losing p16INK4a expression by promoter methylation [45].”
BackgroundDai, H., van't Veer, L., Lamb, J., He, Y. D., Mao, M., Fine, B. M., Bernards, R., van de Vijver, M., Deutsch, P., Sachs, A., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3953 · Cited by 257
Tam, S. W., Shay, J. W., & Pagano, M. (1994) · PubMed · Cited by 222
Identification of a basal-like subtype of breast ductal carcinoma in situ
Livasy, C. A., Perou, C. M., Karaca, G., Cowan, D. W., Maia, D., Jackson, S., Tse, C.-K., Nyante, S., & Millikan, R. C. (2007) · Human Pathology · doi:10.1016/j.humpath.2006.08.017 · Cited by 215
Self-citationGauthier, M. L., Berman, H. K., Miller, C., Kozakeiwicz, K., Chew, K., Moore, D., Rabban, J., Chen, Y. Y., Kerlikowske, K., & Tlsty, T. D. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.10.017 · Cited by 214
Perreard, L., Fan, C., Quackenbush, J. F., Mullins, M., Gauthier, N. P., Nelson, E., Mone, M., Hansen, H., Buys, S. S., Rasmussen, K., et al. (2006) · Breast Cancer Research · doi:10.1186/bcr1399 · Cited by 205
Self-citationVarley, J. M., Armour, J. A. L., Je, S., Jeffreys, A. J., Ponder, B. A., Tang, A. J., Fung, Y. K., Brammar, W. J., & Ra, W. (1989) · PubMed · Cited by 202
The retinoblastoma tumor suppressor modifies the therapeutic response of breast cancer
Bosco, E. E., Wang, Y., Xu, H., Zilfou, J. T., Knudsen, K. E., Aronow, B. J., Lowe, S. W., & Knudsen, E. S. (2007) · Journal of Clinical Investigation · doi:10.1172/jci28803 · Cited by 192
Wang, Z. C., Lin, M., Wei, L.-J., Li, C., Miron, A., Lodeiro, G., Harris, L., Ramaswamy, S., Tanenbaum, D. M., Meyerson, M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2570 · Cited by 190
Valverde, J. R., Alonso, J., Palacios, I., & Pestaña, Á. (2005) · BMC Genetics · doi:10.1186/1471-2156-6-53 · Cited by 177
Milde-Langosch, K., Bamberger, A.-M., Rieck, G., Kelp, B., & Löning, T. (2001) · Breast Cancer Research and Treatment · doi:10.1023/a:1010623308275 · Cited by 159
A Comparison of Gene Expression Signatures from Breast Tumors and Breast Tissue Derived Cell Lines
Ross, D. T., & Perou, C. M. (2001) · Disease Markers · doi:10.1155/2001/850531 · Cited by 143
Self-citationHigh frequency of aberrant p16(INK4A) expression in human breast cancer.
The University of North Carolina at Chapel Hill University Libraries (2020) · PubMed · doi:10.17615/fntc-fr86 · Cited by 136
Hui, R., Macmillan, R. D., Kenny, F. S., Musgrove, E. A., Blamey, R. W., Nicholson, R. I., Robertson, J. F. R., & Sutherland, R. L. (2000) · PubMed · Cited by 120
Hagstrom, S. A., & Dryja, T. P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.2952 · Cited by 118
Borg, Å., Zhang, Q. X., Alm, P., et al. (1992) · PubMed · Cited by 112
Dublin, E. A., Patel, N. K., Gillett, C., Smith, P., Peters, G. G., & Barnes, D. M. (1998) · International Journal of Cancer · Cited by 109
Emig, R., Magener, A., Ehemann, V., Meyer, A.-S., Stilgenbauer, F., Volkmann, M., Wallwiener, D. R., & Sinn, H. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.739 · Cited by 96
Markey, M. P., Bergseid, J., Bosco, E. E., Stengel, K. R., Xu, H., Mayhew, C. N., Schwemberger, S. J., Braden, W. A., Jiang, Y., Babcock, G. F., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210450 · Cited by 78
Truncating mutations of RB1CC1 in human breast cancer
Chano, T., Kontani, K., Teramoto, K., et al. (2002) · Nature Genetics · doi:10.1038/ng911 · Cited by 72
Derenzini, M., Donati, G., Mazzini, G., Montanaro, L., Vici, M., Ceccarelli, C., Santini, D., Taffurelli, M., & Treré, D. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-2065 · Cited by 50
Li, Y., Pan, J., Li, J., Lee, J. H., Tunkey, C., Saraf, K., Garbe, J. C., Whitley, M. Z., Jelinsky, S. A., Stampfer, M. R., et al. (2007) · Molecular Cancer · doi:10.1186/1476-4598-6-7 · Cited by 50
Alterations of p16-pRb Pathway and Chromosome Locus 9p21–22 in Sporadic Invasive Breast Carcinomas
Gorgoulis, V. G., Koutroumbi, E., Kotsinas, A., Zacharatos, P., Markopoulos, C. J., Giannikos, L., Kyriakou, V., Voulgaris, Z., Gogas, I., & Kittas, C. N. (1998) · Molecular Medicine · doi:10.1007/bf03401773 · Cited by 40
Molecular studies of loss of heterozygosity in Chinese sporadic retinoblastoma patients
Zhang, X. L., Fu, W., Zhao, H., Zhou, L. X., Huang, J., & Wang, J. H. (2005) · Clinica Chimica Acta · doi:10.1016/j.cccn.2005.02.013 · Cited by 14
Cited by
Nishimura, R., Osako, T., Nishiyama, Y., Tashima, R., Nakano, M., Fujisue, M., Toyozumi, Y., & Arima, N. (2013) · Oncology · doi:10.1159/000353099 · Cited by 13,166
Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
Prat, A., Parker, J. S., Karginova, O., Fan, C., Livasy, C., Herschkowitz, J. I., He, X., & Perou, C. M. (2010) · Breast Cancer Research · doi:10.1186/bcr2635 · Cited by 2,167
Self-citationThe clonal and mutational evolution spectrum of primary triple-negative breast cancers
Shah, S. P., Roth, A., Goya, R., Oloumi, A., Ha, G., Zhao, Y., Turashvili, G., Ding, J., Tse, K., Haffari, G., et al. (2012) · Nature · doi:10.1038/nature10933 · Cited by 1,967
Treating cancer with selective CDK4/6 inhibitors
O'Leary, B., Finn, R. S., & Turner, N. C. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.26 · Cited by 1,137
Metadata
- Authors
- Herschkowitz, J. I., He, X., Fan, C., & Perou, C. M.
- Venue
- Breast Cancer Research
- Published
- 2008-09-09
- Volume
- 10
- Issue
- 5
- Pages
- R75-R75
- ISSN
- 1465-5411 (ISSN-L)
- 1465-542X
- OpenAlex
- W2141223216
- Cited by
- 255
- References
- 54
- FWCI
- 5.76
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.